Clinical Trial Update: DynamX Bioadaptor Hong Kong Registry [Phase 4]

View source ↗

Summary

Phase 4 Hong Kong registry of the DynamX Bioadaptor has completed enrollment and posted results. The sponsor is Elixir Medical Corporation and the target condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• DynamX Bioadaptor

Snippet

Sponsor: Elixir Medical Corporation | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2024-10-17